Cancer Therapy News and Research

RSS

Retrospective review: Proton therapy well tolerated in patients undergoing breast conserving surgery

While the assessment of proton therapy in breast cancer treatment continues through clinical trials, data relating to early toxicity and cosmetic outcomes for this population are limited.

9 Dec 2019

Experts publish new book with recommendations to reduce Latino cancer

As U.S. Latinos face a staggering 142% projected rise in cancer cases by 2030, UT Health San Antonio leaders gathered international cancer experts to publish a new book with innovative research and recommendations to reduce Latino cancer.

9 Dec 2019

Study shows how a new combination approach helps overcome resistance to cancer immunotherapy

Cancer immunology drugs, which harness the body's immune system to better attack cancer cells, have significantly changed the face of cancer treatment. People with aggressive cancers are now living longer, healthier lives. Unfortunately, cancer immunology therapy only works in a subset of patients.

9 Dec 2019

Hitachi signs agreement to provide CNAO with proton therapy system

Hitachi, Ltd. has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica with its proton therapy system.

9 Dec 2019

Researchers confirm two new prognostic markers for triple negative breast cancer

Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide.

5 Dec 2019

New method for discovering potential cancer-treating compounds

A new study published in the journal Cell Reports reports a novel method by which antitumor drugs that focus on reawakening exhausted immune cells called cytotoxic T cells against cancer can be quickly identified. This could help treat a large subset of cancers that thrive because of their ability to suppress antitumor activity in T cells.

4 Dec 2019

One-third of lung cancer patients have depression symptoms, study finds

About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.

4 Dec 2019

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. Food and Drug Administration, according to a City of Hope-led study.

4 Dec 2019

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.

4 Dec 2019

Study identifies improved treatment option for neuroblastoma

Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, through genome sequencing, that the protein ALK and the cancer gene PIM1 are involved in the development of this tumor.

4 Dec 2019

Transplant patients diagnosed with prostate cancer may not need to delay transplantation

Immunosuppressive medications – drugs given to organ transplant recipients so their bodies won't reject the donor organ - could weaken the immune system's ability to find and destroy cancer or fight infections that contribute to cancer.

3 Dec 2019

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies.

From Sartorius 3 Dec 2019

Discovery could offer insight into different risk of diseases in African Americans

The percentage of African ancestry in a person's genome determines the level that certain genes are expressed, called mRNA, according to a new Northwestern Medicine study.

3 Dec 2019

Low-cost intervention can increase self-esteem of young cancer survivors

Young cancer survivors face unique medical and psychosocial challenges that can hinder their ability to move on mentally and socially, even years after their final treatment.

2 Dec 2019

New $300,000 grant-funded program to address opioid prescribing for cancer patients

The University of Illinois at Chicago has received a grant from the Coleman Foundation to develop a screening process for prescribing opioids and managing opioid use disorders in cancer patients who receive care at UI Health, UIC's clinical health enterprise.

2 Dec 2019

Painful endometriosis symptoms could be reduced with a cancer drug

The painful symptoms of endometriosis - a chronic condition which affects millions of women - could potentially be reduced with a drug that had previously been investigated as a cancer treatment.

2 Dec 2019

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

27 Nov 2019

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.

26 Nov 2019

Cancer patients more likely to die from heart disease, stroke, study found

Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don’t die from cancer itself, rather from heart and blood vessel conditions.

25 Nov 2019

New targeted treatment to fight against deadly pancreatic cancer

Every day, more than 1200 people worldwide are told they have pancreatic cancer. Within 12 months, 80 per cent of them will have succumbed to the disease.

25 Nov 2019

Cancer Therapy News and Research

Retrospective review: Proton therapy well tolerated in patients undergoing breast conserving surgery

Experts publish new book with recommendations to reduce Latino cancer

Study shows how a new combination approach helps overcome resistance to cancer immunotherapy

Hitachi signs agreement to provide CNAO with proton therapy system

Researchers confirm two new prognostic markers for triple negative breast cancer

New method for discovering potential cancer-treating compounds

One-third of lung cancer patients have depression symptoms, study finds

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Study identifies improved treatment option for neuroblastoma

Transplant patients diagnosed with prostate cancer may not need to delay transplantation

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Discovery could offer insight into different risk of diseases in African Americans

Low-cost intervention can increase self-esteem of young cancer survivors

New $300,000 grant-funded program to address opioid prescribing for cancer patients

Painful endometriosis symptoms could be reduced with a cancer drug

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Cancer patients more likely to die from heart disease, stroke, study found

New targeted treatment to fight against deadly pancreatic cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News